HETEROCYCLES, Vol. 65, No. 1, 2005
21
(25), 177(12), 176 (44), 162 (13), 148 (22), 136 (33), 134 (14), 122 (37), 105 (80), 104 (33), 77 (37), 56
(12), 55 (11), 51 (10), 41 (17); HRMS m/z calcd for C13H17NO2Na 242.1147 found 242.1169. Anal.
Calcd for C13H17NO2: C 71.21, H 7.81, N 6.39. Found: C 71.25, H 7.74, N 6.14.
6-Hydroxy-3,3,4,4-tetramethyl-6-phenylpiperidin-2-one (24). Obtained from compound (18) (608 mg,
3.6 mmol) and purified by column chromatography on silica gel using benzene and ethyl acetate as
eluents, starting from pure benzene to benzene:ethyl acetate (1:1 v/v). It gave 525 mg of 24, 59%, mp
1
143-144°C. Recrystallized from benzene. H NMR (benzene-d6, 500 MHz) δ 0.54 (s, 3H), 0.86 (s, 3H),
1.02 (s, 3H), 1.15 (s, 3H), 1.85 (qAB, J=14.5 Hz), 5.00 (s, 1H, disappeared with D2O), 7.08 (tt, 1H, J1=7.8,
J2=1.5 Hz), 7.17 (td, 2H, J1=7.8, J2=1.5 Hz), 7.29 (s, 1H, disappeared with D2O), 7.55 (dt, 2H, J1=7.7,
J2=1.5 Hz); 13C NMR (benzene-d6, 125 MHz) δ 19.3, 23.2, 24.7, 26.2, 35.6, 44.4, 48.0, 84.0, 125,4, 127.8,
128.6, 148.5, 179.6; MS (EI) m/z (rel intensity in %) 247 (M+, 4), 230 (39), 229 (23), 215 (16), 214 (100),
199(11), 191 (18), 170 (21), 160 (23), 128 (10), 122 (18), 105 (19), 104 (10), 84 (82), 83 (10), 77 (21), 70
(12), 69 (41), 55 (12), 41 (24); IR (KBr, cm-1) 3295, 2975, 1655, 1625, 1405, 1170; HRMS m/z calcd for
C15H21NO2Na 270.1470 found 270.1476. Anal. Calcd for C15H21NO2: C 72.84, H 8.56, N 5.66. Found: C
73.01, H 8.66, N 5.48.
3,3-Dimethyl-6-phenyl-3,4-dihydropyridin-2(1H)-one (17). Keto amide (15) (100 mg, 0.46 mmol) was
dissolved in 5 mL of chloroform and one drop of BF3 etherate was added. After 30 min the solvents were
removed and a short-path chromatography on neutral aluminum oxide was performed with chloroform as
1
eluent, giving compound (17) (90 mg, 98%), mp 143°C. Recrystallized from CHCl3. H NMR (CDCl3,
500 MHz) δ 1.25 (s, 6H), 2.37 (d, J=5.0 Hz, 2H), 5.41 (td, 1H, J1=5.0, J2=1.8 Hz), 7.10 (br s, 1H,
disappeared with D2O), 7.40 (m, 5H); 13C NMR (CDCl3, 125 MHz) δ 24.5, 36.0, 36.9, 101.7, 124.7,
128.7, 128.9, 135.0, 136.3, 177.1; MS (ES) [M+H]+ = 202. Anal. Calcd for C13H15NO: C 77.58, H 7.51,
N 6.96. Found: C 77.42, H 7.39, N 6.61.
3,3,4,4-tetramethyl-6-phenyl-3,4-dihydropyridin-2(1H)-one (25). Attempted purification of compound
(24) (100 mg, 0,4 mmol) by recrystallization from chloroform gave compound 25 (92 mg, 99%), mp
1
137°C. H NMR (CDCl3, 200 MHz) δ 1.09 (s, 6H), 1.17 (s, 6H), 5.17 (d, 1H, J=1.8 Hz), 7.11 (bs, 1H,
13
disappeared with D2O), 7.34-7.41 (m, 5H); C NMR (CDCl3, 50 MHz) δ 19.2, 23.0, 37.4, 44.3, 114.5,
124.7, 128.6, 128.9, 133.0, 134.9, 178.0; IR (KBr, cm-1) 3200, 3105, 2975, 1675, 1660, 1345; MS (EI)
m/z (rel intensity in %) 229 (M+, 30), 215 (15), 214 (100), 199 (12), 160 (22), 143 (10); HRMS m/z for
C15H19NONa 252.1364 found 252.1335. Anal. Calcd for C15H19NO: C 78.56, H 8.35, N 6.11. Found: C
78.65, H 8.21, N 5.89.
ACKNOWLEDGEMENTS
We are very grateful to Prof. K. Woźniak from Warsaw University, Faculty of Chemistry, Laboratory of
Crystallochemistry, for making the X-Ray measurement for compound (24).